MRPL37P1

Across TCGA pan-cancer cohorts, MRPL37P1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MRPL37P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MRPL37P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MRPL37P1 is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.

KIRC, STAD, and KICH are the cancer types where MRPL37P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MRPL37P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.064	.012	6	view →
STAD	Male	All	+0.279	.004	4	view →
KICH	All	III,IV	−0.068	.004	4	view →
HNSC	All	All	+0.060	.010	4	view →
BRCA	All	III,IV	−0.094	.006	2	view →
CHOL	All	All	+0.036	.007	2	view →
LUSC	All	II,III,IV	+0.090	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MRPL37P1–KIRC

Open the KIRC breakdown →